Multiple Sclerosis in the
Managed Care Setting
Webcast CME Disclosure
Please read this notice and click the acknowledgement
at the bottom of the page to continue.
Estimated Time to Complete Educational Activity
In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in multiple sclerosis.
December 11, 2012
December 11, 2014
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period December 11, 2012 through December 11, 2014, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all six segments totaling 4.0 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form; and 4) print out your CME certificate.
Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
This CME activity is supported
by an educational grant from
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Complete Conference Management and CMEducation Resources, LLC. Complete Conference Management is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Complete Conference Management designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
It is the policy of Complete Conference Management to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by Complete Conference Management are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Program Faculty and Disclosure
THOMAS P. LEIST, MD, PhD – Program Chairman
Associate Professor of Neurology
Chief, Division of Clinical Neuroimmunology
Director, Comprehensive Multiple Sclerosis Center
Thomas Jefferson University
Advisory Board: Sanofi Genzyme
Research Grants: Biogen Idec, Teva, EMD Serono, Novartis, Acorda
Speaker Honoraria: Biogen Idec, Teva, EMD Serono, Novartis, Questcor, Acorda
Consultant: Biogen Idec, Teva, EMD Serono, Novartis, Questcor, Acorda
BRIAN STEINGO, MD
Director, Fort Lauderdale MS Center
Sunrise Medical Group
Pompano Beach, FL
Research Grants: Teva, Genzyme
Speaker Honoraria: Teva
Consultant/Advisory Board: Teva, Novartis, Genzyme
RONALD J. DEBELLIS, PharmD, FCCP
Professor and Chair, Department of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Speaker Honoraria: Teva
Consultant/Advisory Board: Pfizer
DAVID MEYER, MD
Triad Neurological Associates/Cornerstone Healthcare
Winston Salem, NC
Research Grant: Biogen Idec
Speaker Honoraria: Biogen-Idec, EMD Serono/Pfizer, Bayer, Berlex, Teva, Novartis
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose.
Upon completion of this activity, participants will be able to:
- Compare injectable IMTs used for initial, first-line foundation therapy in MS, with a focus on safety, efficacy, and long-term clinical experience
- Describe the molecular mechanisms of established, injectable IMTs and their effects on neuroimmunological signaling systems, neuroinflammation, and neuronal preservation
- Discuss how the possible approval of new MS therapies—including both oral and injectable agents without long-term safety profiles—may change the risk- to-benefit proposition for and influence long-term treatment decisions for MS treatment regimens implemented in the managed care setting
- Detail the clinical risks and benefits of established, injectable IMTs for MS, and how the safety profiles of these platform agents with documented long-term safety and LTFU studies showing EDSS stabilization and reduction in relapse rates
- List the requirements for pharmacovigilance programs that are currently in place for MS therapies, and how pharmacoviligance programs for MS therapies used in managed care settings will need to adapt and change when potentially new, immunosuppressive therapies with a variable range of adverse effects and toxicities become available
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
- We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
- For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
- We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
- If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Copyright © 2012 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations
||I have read
this CME information statement and wish to participate in this CME
Copyright © CMEducation Resources, LLC and Pharmatecture, LLC